Avalo Therapeutics, Inc. (AVTX): Operating Income
-$72.92M
Year ended 2025-12-31
-$91.36M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$72.92M | n/m | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | -$68.51M | n/m | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | -$27.35M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$37.44M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$82.13M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$72.84M | n/m | 2022-03-02, From 2020-01-01 |
| 2019-12-31 | -$16.14M | n/m | 2021-03-08, From 2019-01-01 |
| 2018-12-31 | -$35.38M | n/c | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $13.89M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$16.08M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$11.01M | n/m | 2018-04-02, From 2015-01-01 |
| 2014-12-31 | -$17.12M | n/m | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | -$12.93M | n/a | 2016-03-23, From 2013-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$72.92M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$58.07M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$13.16M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$86.82M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.28M | n/m |
| Altimmune, Inc. (ALT) | 2025-12-31 | -$94.49M | n/m |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | -$23.79M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$58.24M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$36.25M | n/m |
Compare AVTX, CNTB, HCWB, INO side by side · Screen every company in Pharmaceutical Preparations ↗